data-moat — tisram

Bain & Company 2026-05-19-3

Bain's Synthetic Customer 90% Claim — Read the Timing, Not the Number

Bain claims digital twins replicate 90% of conjoint outcomes — but publishes no methodology, no failure cases, no out-of-distribution quantification, and no vendor benchmarks. What's actually informative isn't the number, it's the timing: Bain typically publishes capability validation 12-18 months after early adopters prove the case and 6-12 months before mass deployment (digital transformation 2014→2017, cloud 2012→2015, data warehouse 2018→2021). The consulting capture window is what's predictable here, not the 90% itself — and whether Nielsen and Kantar pivot offensively or get compressed is the open question the paper doesn't touch.

# tags

synthetic-cohorts ai-1.0-defensibility enterprise-ai-adoption consulting market-research-disruption ai-economics build-vs-buy data-moat agentic-ai-viability first-party-data bain

NBC News · 2026-05-14 2026-05-15-w2

OpenEvidence: Most physicians quietly use this medical AI tool

OpenAI launched ChatGPT for Clinicians in April without licensing NEJM or JAMA. OpenEvidence has both, and the market repriced it from $1B to $12B in 15 months on the back of 65% US physician reach and 27 million April clinical encounters. The binding constraint for entering credentialed verticals was never model quality; it was licensed-data governance and the operational-regime approval that comes with it. The Deployment Company and the LF Networking pattern this week are structurally identical: the moat that holds isn't capability, it's the layer of credential, distribution, or implementation sitting above it. For frontier labs, that means the verticals with the clearest content-licensing moats (clinical, legal, financial) will reprice fastest against whoever shows up without the corpus.

NBC News 2026-05-14-2

OpenEvidence: Most physicians quietly use this medical AI tool

OpenAI launched ChatGPT for Clinicians in April without licensing NEJM or JAMA. OpenEvidence has both, hit 65% of US physicians across 27 million April clinical encounters, and got repriced from $1B to $12B in 15 months. The binding constraint for frontier labs entering credentialed verticals is content licensing, not model capability, and OpenAI just supplied the revealed-preference proof.

Reuters 2026-04-23-1

Meta to Capture Employee Keystrokes and Screen Snapshots for AI Agent Training

Meta just made the harvest-then-replace cycle an explicit corporate program: install tracking software, capture employee keystrokes and screen snapshots, feed an Applied AI team building the agents that will handle the work, then lay off 10% in May. The surveillance framing will dominate headlines; the investment signal is quieter and bigger. Every F500 employer with more than 10,000 knowledge workers now holds a latent AI training asset on its balance sheet, and the first to build the governance layer around it will define the next decade of enterprise software economics.